Engineers Gate Manager LP Fibrogen Inc Transaction History

Engineers Gate Manager LP

$4.86 Billion
Q3 2024

A detailed history of Engineers Gate Manager LP transactions in Fibrogen Inc stock. As of the latest transaction made, Engineers Gate Manager LP holds 85,233 shares of FGEN stock, worth $57,106. This represents 0.0% of its overall portfolio holdings.

Number of Shares

85,233

Previous 85,233 -0.0%

Holding current value

$57,106

Previous $75,000 54.67%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.89 - $2.36 $65 - $174	74 Added 0.09%	85,233 $75,000
Q1 2024 May 15, 2024	BUY	$0.73 - $2.73 $112 - $420	154 Added 0.18%	85,159 $200,000
Q4 2023 Feb 14, 2024	SELL	$0.38 - $0.91 $940 - $2,251	-2,474 Reduced 2.83%	85,005 $75,000
Q3 2023 Nov 14, 2023	SELL	$0.79 - $2.83 $19,599 - $70,212	-24,810 Reduced 22.09%	87,479 $75,000
Q2 2023 Aug 14, 2023	BUY	$2.49 - $20.59 $235,837 - $1.95 Million	94,714 Added 538.91%	112,289 $303,000
Q1 2023 May 15, 2023	BUY	$15.95 - $25.18 $280,321 - $442,538	17,575 New	17,575 $327,000
Q1 2022 May 16, 2022	SELL	$12.02 - $16.79 $208,619 - $291,407	-17,356 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$9.93 - $15.39 $771,908 - $1.2 Million	-77,735 Reduced 81.75%	17,356 $245,000
Q3 2021 Nov 15, 2021	BUY	$10.18 - $26.64 $968,026 - $2.53 Million	95,091 New	95,091 $972,000
Q1 2021 May 17, 2021	SELL	$31.0 - $55.72 $535,773 - $963,008	-17,283 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$37.09 - $48.97 $641,026 - $846,348	17,283 New	17,283 $641,000
Q3 2020 Nov 16, 2020	SELL	$40.47 - $45.5 $251,399 - $282,646	-6,212 Closed	0 $0
Q2 2020 Aug 17, 2020	SELL	$32.57 - $42.83 $16,089 - $21,158	-494 Reduced 7.37%	6,212 $252,000
Q1 2020 May 15, 2020	BUY	$23.3 - $45.96 $156,249 - $308,207	6,706 New	6,706 $233,000

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $62.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Account

Engineers Gate Manager LP Fibrogen Inc Transaction History